BioCentury
ARTICLE | Company News

Xoma, Triton BioSystems Inc. deal

October 11, 2004 7:00 AM UTC

Triton received exclusive worldwide rights to use XOMA's human engineered ING-1 monoclonal antibody to deliver Triton's targeted nano-therapeutics, which are magnetic spheres that heat up and ablate t...